Variant position: 153 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 392 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human HYTLQEVEEGLAQHKPVLLF LTHGESSTGVLQPLDGFGELC
Mouse HYTLQEVEEGLAQHKPVLLF LVHGESSTGVVQPLDGFGELC
Rat HYTLQEVEEGLAQHKPVLLF LTHGESSTGVLQPLDGFGELC
Rabbit HYTLQEVEECLAQHKPVLLF LTHGESSTGVLQPLDGFGELC
Cat HYTLQELEEALAQHKPVLLF LTQGESSSGVLQPLDGYGELC
Slime mold WFALEEIESALVQHKPSLLT LVFGETSTGVKQQMEGVGELC
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 392 Alanine--glyoxylate aminotransferase
149 – 156
Clinical implications of mutation analysis in primary hyperoxaluria type 1.
van Woerden C.S.; Groothoff J.W.; Wijburg F.A.; Annink C.; Wanders R.J.A.; Waterham H.R.;
Kidney Int. 66:746-752(2004)
Cited for: VARIANTS HP1 ARG-82; ILE-152; VAL-153; ARG-170 AND ASP-336;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.